Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

Devenish SO, Patel SD, Ussingkær LV, Almeida Silva LF, Goff O, Richardson A, Mobbs JI, Venugopal H, Thal DM, Kullmann DM.

Open source

DOI: 10.1038/s41392-026-02865-4
Published: 2026-07-03
Container: Signal Transduct Target Ther
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41392-026-02865-4,
  title = {Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.},
  author = {Devenish SO and  Patel SD and  Ussingkær LV and  Almeida Silva LF and  Goff O and  Richardson A and  Mobbs JI and  Venugopal H and  Thal DM and  Kullmann DM.},
  year = {2026},
  journal = {Signal Transduct Target Ther},
  doi = {10.1038/s41392-026-02865-4},
  url = {https://doi.org/10.1038/s41392-026-02865-4}
}

RIS

TY  - JOUR
TI  - Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.
AU  - Devenish SO
AU  -  Patel SD
AU  -  Ussingkær LV
AU  -  Almeida Silva LF
AU  -  Goff O
AU  -  Richardson A
AU  -  Mobbs JI
AU  -  Venugopal H
AU  -  Thal DM
AU  -  Kullmann DM.
PY  - 2026
JO  - Signal Transduct Target Ther
DO  - 10.1038/s41392-026-02865-4
UR  - https://doi.org/10.1038/s41392-026-02865-4
ER  -

APA

SO, D., SD, P., LV, U., LF, A. S., O, G., A, R., JI, M., H, V., DM, T., & DM., K. (2026). Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.. Signal Transduct Target Ther. https://doi.org/10.1038/s41392-026-02865-4

Source records

europe-pmc · retrieved 2026-09-27T12:07:57.362Z
doaj · retrieved 2026-09-27T12:07:57.352Z